Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

ARYx Therapeutics, Inc. (ARYX)

-Other OTC
0.01 0.00(0.00%) Apr 17, 1:16PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2009Dec 31, 2008Dec 31, 2007
Total Revenue -   19,724   4,158  
Cost of Revenue -  232  262  
Gross Profit -   19,492   3,896  
Operating Expenses
Research Development21,040  40,145  24,994  
Selling General and Administrative10,198  9,764  7,702  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (31,238) (30,417) (28,800)
Income from Continuing Operations
Total Other Income/Expenses Net78  1,127  2,591  
Earnings Before Interest And Taxes(31,160)(29,290)(26,209)
Interest Expense2,007  1,928  1,352  
Income Before Tax(33,167)(31,218)(27,561)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(33,167)(31,218)(27,561)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (33,167) (31,218) (27,561)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (33,167) (31,218) (27,561)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.